Ritholtz Wealth Management
GSK icon

Ritholtz Wealth Management’s GSK GSK Stock Holding History

Ritholtz Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.62M Buy
75,182
+2,037
+3% +$104K 0.05% 265
2026
Q2 		$3.83M Buy
73,145
+6,418
+10% +$339K 0.06% 243
2026
Q1 		$3.68M Buy
66,727
+8,223
+14% +$446K 0.06% 231
2025
Q4 		$2.87M Buy
58,504
+12,905
+28% +$602K 0.05% 268
2025
Q3 		$1.97M Sell
45,599
-22,605
-33% -$883K 0.04% 335
2025
Q2 		$2.62M Buy
68,204
+16,691
+32% +$638K 0.06% 230
2025
Q1 		$2M Sell
51,513
-20,420
-28% -$748K 0.06% 251
2024
Q4 		$2.43M Sell
71,933
-6,607
-8% -$238K 0.07% 193
2024
Q3 		$3.21M Buy
78,540
+2,143
+3% +$87.7K 0.1% 145
2024
Q2 		$2.94M Sell
76,397
-1,147
-1% -$48.2K 0.1% 144
2024
Q1 		$3.32M Buy
77,544
+21,497
+38% +$887K 0.11% 123
2023
Q4 		$2.08M Sell
56,047
-994
-2% -$35.7K 0.08% 162
2023
Q3 		$2.07M Buy
57,041
+881
+2% +$31.3K 0.09% 135
2023
Q2 		$2M Sell
56,160
-5,981
-10% -$215K 0.09% 142
2023
Q1 		$2.21M Sell
62,141
-9,881
-14% -$346K 0.11% 117
2022
Q4 		$2.53M Buy
72,022
+28,322
+65% +$943K 0.14% 102
2022
Q3 		$1.29M Buy
43,700
+9,916
+29% +$376K 0.07% 199
2022
Q2 		$1.84M Buy
33,784
+9,536
+39% +$526K 0.12% 103
2022
Q1 		$1.32M Buy
24,248
+6,985
+40% +$379K 0.09% 139
2021
Q4 		$952K Buy
17,263
+6,369
+58% +$331K 0.06% 176
2021
Q3 		$520K Buy
10,894
+1,235
+13% +$62K 0.04% 260
2021
Q2 		$481K Buy
9,659
+2,975
+45% +$143K 0.03% 257
2021
Q1 		$298K Buy
6,684
+2,158
+48% +$98K 0.02% 304
2020
Q4 		$208K Sell
4,526
-780
-15% -$35.8K 0.02% 337
2020
Q3 		$250K Sell
5,306
-1,211
-19% -$60.7K 0.03% 234
2020
Q2 		$332K Buy
+6,517
New +$334K 0.04% 162

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Letko, Brosseau & Associates
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Ritholtz Wealth Management's GSK Position: Q3 2026 in Review

Ritholtz Wealth Management increased its GSK (GSK) stake by 2.8% in Q3 2026, buying an estimated $104K and bringing the position to 75,182 shares worth $3.62M. The position accounts for 0.05% of the portfolio, ranked #265.

Ritholtz Wealth Management first reported a position in GSK in Q2 2020 and has held it in 26 quarters since. The position peaked at $3.83M in Q2 2026. 602 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Ritholtz Wealth Management held 75,182 shares of GSK worth $3.62M as of Q3 2026.
  • Ritholtz Wealth Management bought 2,037 GSK shares in Q3 2026, an estimated $104K.
  • GSK made up 0.05% of Ritholtz Wealth Management's portfolio in Q3 2026, its #265 holding.
  • Ritholtz Wealth Management first reported a position in GSK in Q2 2020 and has held it in 26 quarters since.
  • Ritholtz Wealth Management's GSK position peaked at $3.83M in Q2 2026.
  • 602 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.